Barclay Phillips
Board Member
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barclay Phillips
Barclay Phillips is recorded as Board Member at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed June 4, 2025 that Barclay Phillips was appointed Class II Director, effective June 4, 2025.
“To elect Dr. Jörg Neermann, Ms. Tamar Howson, and Mr. Barclay Phillips as Class II Directors to serve until our 2028 annual meeting of stockholders and until their successors are duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.